LMW-E/CDK2 Deregulates Acinar Morphogenesis, Induces Tumorigenesis, and Associates with the Activated b-Raf-ERK1/2-mTOR Pathway in Breast Cancer Patients

LMW-E/CDK2 Deregulates Acinar Morphogenesis, Induces Tumorigenesis, and Associates with the Activated b-Raf-ERK1/2-mTOR Pathway in Breast Cancer Patients

Elastase-mediated cleavage of cyclin E generates low molecular weight cyclin E (LMW-E) isoforms exhibiting enhanced CDK2–associated kinase activity and resistance to inhibition by CDK inhibitors p21 and p27. Approximately 27% of breast cancers express high LMW-E protein levels, which significantly c...

Full description

Bibliographic Details
Main Authors: Duong, MyLinh T., Akli, Said, Wei, Caimiao, Wingate, Hannah F., Liu, Wenbin, Lu, Yiling, Yi, Min, Mills, Gordon B., Hunt, Kelly K., Keyomarsi, Khandan
Format: Online
Language:English
Published: Public Library of Science 2012
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3315462/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3315462/

Similar Items